Athira Pharma, Inc.(ATHA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ATHA Athira Pharma, Inc.

休市中 12-19 16:00:00 EST

6.97

+0.25

+3.72%

盘后6.98

+0.01+0.14%

19:59 EST

最高7.25	最低6.37	成交量140.34万
今开6.71	昨收6.72	日振幅13.10%
总市值2,749万	流通市值1,764万	总股本394.39万
成交额961.02万	换手率55.46%	流通股本253.03万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ATHA","market":"US","secType":"STK","nameCN":"Athira Pharma, Inc.","latestPrice":6.97,"timestamp":1766178000000,"preClose":6.72,"halted":0,"volume":1403375,"hourTrading":{"tag":"盘后","latestPrice":6.98,"preClose":6.97,"latestTime":"19:59 EST","volume":46040,"amount":318609.4911,"timestamp":1766192364298},"delay":0,"floatShares":2530271,"shares":3943887,"eps":-9.65516,"marketStatus":"休市中","change":0.25,"latestTime":"12-19 16:00:00 EST","open":6.71,"high":7.25,"low":6.37,"amount":9610153.418625,"amplitude":0.130952,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.65516,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"adr":0,"listingDate":1600401600000,"exchange":"NASDAQ","adjPreClose":6.72,"preHourTrading":{"tag":"盘前","latestPrice":6.72,"preClose":6.72,"latestTime":"09:29 EST","volume":72550,"amount":474785.11985,"timestamp":1766154576173},"postHourTrading":{"tag":"盘后","latestPrice":6.98,"preClose":6.97,"latestTime":"19:59 EST","volume":46040,"amount":318609.4911,"timestamp":1766192364298},"volumeRatio":0.1159190900786083,"impliedVol":1.069,"impliedVolPercentile":0.5189},"requestUrl":"/m/hq/s/ATHA","defaultTab":"news","newsList":[{"id":"2592139429","title":"Cardio Diagnostics Holdings Inc.盘中异动 早盘股价大涨6.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592139429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592139429?lang=zh_cn&edition=full","pubTime":"2025-12-18 23:08","pubTimestamp":1766070539,"startTime":"0","endTime":"0","summary":"北京时间2025年12月18日23时08分，Cardio Diagnostics Holdings Inc.股票出现波动，股价快速上涨6.79%。Cardio Diagnostics Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.61%。其相关个股中，Athira Pharma, Inc.、健永生技、Day One Biopharmaceuticals, Inc.涨幅较大，Athira Pharma, Inc.、Biodexa Pharmaceuticals Plc、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为1075.17%、183.75%、53.78%，振幅较大的相关个股有健永生技、Athira Pharma, Inc.、Werewolf Therapeutics, Inc.，振幅分别为39.69%、29.02%、22.54%。Cardio Diagnostics Holdings Inc.公司简介：Cardio Diagnostics Holdings Inc 是一家医疗技术公司，专注在开发和商业化基于表观遗传学的心血管疾病临床测试。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218230900a6b3283b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218230900a6b3283b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDIO","BK4139","ATHA","BK4007"],"gpt_icon":0},{"id":"2592501189","title":"Cibus, Inc.盘中异动 早盘大幅上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592501189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592501189?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:53","pubTimestamp":1766069601,"startTime":"0","endTime":"0","summary":"北京时间2025年12月18日22时53分，Cibus, Inc.股票出现波动，股价大幅拉升5.14%。截至发稿，该股报1.62美元/股，成交量7503股，换手率0.01%，振幅1.30%。Cibus, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Athira Pharma, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Cdt Equity Inc C/Wts 22/09/2028涨幅较大，Athira Pharma, Inc.、Biodexa Pharmaceuticals Plc、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为964.78%、169.42%、48.20%，振幅较大的相关个股有Athira Pharma, Inc.、Werewolf Therapeutics, Inc.、健永生技，振幅分别为27.33%、22.54%、22.22%。Cibus, Inc.公司简介：Cibus Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218225321953b6c64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218225321953b6c64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CBUS","BK4139","ATHA"],"gpt_icon":0},{"id":"2592927134","title":"Orchestra Biomed Holdings, Inc.盘中异动 股价大涨6.05%报4.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592927134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592927134?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:47","pubTimestamp":1766069265,"startTime":"0","endTime":"0","summary":"北京时间2025年12月18日22时47分，Orchestra Biomed Holdings, Inc.股票出现波动，股价急速上涨6.05%。Orchestra Biomed Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Orchestra Biomed Holdings, Inc.公司简介：Orchestra BioMed Holdings Inc 是一家生物医学创新公司，通过风险共担和利益共享的合作伙伴关系，加速将高影响力技术推向患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121822474597a07658&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121822474597a07658&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4082","OBIO","ATHA"],"gpt_icon":0},{"id":"1148452626","title":"Athira Pharma融资由Commodore Capital、Perceptive Advisors和Tcgx共同主导，Adar1等参与","url":"https://stock-news.laohu8.com/highlight/detail?id=1148452626","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148452626?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:05","pubTimestamp":1766059530,"startTime":"0","endTime":"0","summary":"Athira Pharma融资由Commodore Capital、Perceptive Advisors和Tcgx共同主导，Adar1等参与","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATHA","BK4007"],"gpt_icon":0},{"id":"1137238884","title":"Athira Pharma宣布独家许可Lasofoxifene三期开发计划用于转移性乳腺癌，并融资最高达2.36亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1137238884","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137238884?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:05","pubTimestamp":1766059529,"startTime":"0","endTime":"0","summary":"Athira Pharma宣布独家许可Lasofoxifene三期开发计划，用于转移性乳腺癌候选药物，并融资最高达2.36亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ATHA"],"gpt_icon":0},{"id":"2586290959","title":"Athira Pharma, Inc.盘中异动 早盘急速拉升7.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586290959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586290959?lang=zh_cn&edition=full","pubTime":"2025-11-27 00:12","pubTimestamp":1764173545,"startTime":"0","endTime":"0","summary":"北京时间2025年11月27日00时12分，Athira Pharma, Inc.股票出现波动，股价急速上涨7.19%。Athira Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127001225a7135677&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127001225a7135677&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATHA","BK4007"],"gpt_icon":0},{"id":"2583586580","title":"Athira Pharma, Inc.盘中异动 大幅上涨5.08%报4.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583586580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583586580?lang=zh_cn&edition=full","pubTime":"2025-11-12 23:24","pubTimestamp":1762961055,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日23时24分，Athira Pharma, Inc.股票出现波动，股价快速拉升5.08%。截至发稿，该股报4.86美元/股，成交量614股，换手率0.02%，振幅0.00%。Athira Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111223241695002c83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111223241695002c83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATHA","BK4007"],"gpt_icon":0},{"id":"1173015900","title":"Athira Pharma, Inc.：Mizuho因应10:1反向股票分割将目标价从5美元调整至4美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1173015900","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173015900?lang=zh_cn&edition=full","pubTime":"2025-09-19 17:51","pubTimestamp":1758275473,"startTime":"0","endTime":"0","summary":"Athira Pharma, Inc.：Mizuho因应10:1反向股票分割将目标价从5美元调整至4美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ATHA"],"gpt_icon":0},{"id":"2568029734","title":"Athira Pharma, Inc.盘中异动 早盘快速拉升5.69%报4.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568029734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568029734?lang=zh_cn&edition=full","pubTime":"2025-09-18 21:40","pubTimestamp":1758202801,"startTime":"0","endTime":"0","summary":"北京时间2025年09月18日21时40分，Athira Pharma, Inc.股票出现异动，股价急速拉升5.69%。截至发稿，该股报4.00美元/股，成交量1417股，换手率0.04%，振幅0.78%。Athira Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918214001a4cdd994&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918214001a4cdd994&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATHA","BK4007"],"gpt_icon":0},{"id":"2566876549","title":"Athira Pharma, Inc.盘中异动 急速下跌5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566876549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566876549?lang=zh_cn&edition=full","pubTime":"2025-09-10 21:46","pubTimestamp":1757511981,"startTime":"0","endTime":"0","summary":"北京时间2025年09月10日21时46分，Athira Pharma, Inc.股票出现异动，股价大幅下挫5.70%。Athira Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.49%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091021462195217b83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091021462195217b83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATHA","BK4007"],"gpt_icon":0},{"id":"2557152726","title":"Athira Pharma, Inc.盘中异动 股价大涨7.43%报0.398美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557152726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557152726?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:36","pubTimestamp":1754660186,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时36分，Athira Pharma, Inc.股票出现异动，股价急速拉升7.43%。截至发稿，该股报0.398美元/股，成交量3.9871万股，换手率0.10%，振幅3.38%。Athira Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808213626a47d5cf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808213626a47d5cf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ATHA"],"gpt_icon":0},{"id":"2557456956","title":"Athira Pharma, Inc.盘中异动 早盘大幅跳水5.01%报0.360美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557456956","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557456956?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:36","pubTimestamp":1754573769,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日21时36分，Athira Pharma, Inc.股票出现波动，股价大幅跳水5.01%。截至发稿，该股报0.360美元/股，成交量3060股，换手率0.01%，振幅1.69%。Athira Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080721360994d5a0ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080721360994d5a0ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATHA","BK4007"],"gpt_icon":0},{"id":"2557970423","title":"Athira Pharma, Inc.盘中异动 快速拉升5.04%报0.390美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557970423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557970423?lang=zh_cn&edition=full","pubTime":"2025-08-05 21:35","pubTimestamp":1754400931,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日21时35分，Athira Pharma, Inc.股票出现异动，股价大幅上涨5.04%。截至发稿，该股报0.390美元/股，成交量1119股，换手率0.00%，振幅0.00%。Athira Pharma, Inc.股票所在的生物技术行业中，整体跌幅为3.32%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805213532a476b834&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805213532a476b834&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATHA","BK4007"],"gpt_icon":0},{"id":"2556188382","title":"Athira Pharma, Inc.盘中异动 股价大涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556188382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556188382?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:32","pubTimestamp":1754314342,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时32分，Athira Pharma, Inc.股票出现异动，股价急速上涨5.35%。Athira Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Psyence Biomedical Ltd.、Soligenix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为2217.65%、801.47%、388.27%，振幅较大的相关个股有Psyence Biomedical Ltd.、凯信远达、Bioxcel Therapeutics, Inc.，振幅分别为21.40%、15.35%、13.50%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213222a4748fcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213222a4748fcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATHA","BK4007"],"gpt_icon":0},{"id":"2555839357","title":"Athira Pharma, Inc.盘中异动 股价大涨5.88%报0.378美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555839357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555839357?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:56","pubTimestamp":1753970218,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时56分，Athira Pharma, Inc.股票出现波动，股价快速上涨5.88%。截至发稿，该股报0.378美元/股，成交量1.6458万股，换手率0.04%，振幅2.61%。Athira Pharma, Inc.股票所在的生物技术行业中，整体涨幅为2.17%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731215658a6cbd638&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731215658a6cbd638&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATHA","BK4007"],"gpt_icon":0},{"id":"2555504190","title":"Athira Pharma, Inc.盘中异动 早盘急速跳水5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555504190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555504190?lang=zh_cn&edition=full","pubTime":"2025-07-29 23:11","pubTimestamp":1753801900,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日23时11分，Athira Pharma, Inc.股票出现波动，股价快速跳水5.28%。Athira Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072923114194c1cd27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072923114194c1cd27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ATHA"],"gpt_icon":0},{"id":"2554477745","title":"Athira Pharma, Inc.盘中异动 急速跳水7.07%报0.426美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554477745","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554477745?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:52","pubTimestamp":1753710742,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时52分，Athira Pharma, Inc.股票出现波动，股价快速跳水7.07%。截至发稿，该股报0.426美元/股，成交量2.4252万股，换手率0.06%，振幅2.97%。Athira Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728215222a467e16f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728215222a467e16f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATHA","BK4007"],"gpt_icon":0},{"id":"2552484745","title":"Athira Pharma, Inc.盘中异动 股价大涨8.57%报0.417美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552484745","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552484745?lang=zh_cn&edition=full","pubTime":"2025-07-17 21:42","pubTimestamp":1752759729,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日21时42分，Athira Pharma, Inc.股票出现异动，股价快速拉升8.57%。截至发稿，该股报0.417美元/股，成交量1.9675万股，换手率0.05%，振幅4.45%。Athira Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717214209a6affb43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717214209a6affb43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATHA","BK4007"],"gpt_icon":0},{"id":"2551125110","title":"Athira Pharma, Inc.盘中异动 急速下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551125110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551125110?lang=zh_cn&edition=full","pubTime":"2025-07-16 21:40","pubTimestamp":1752673239,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日21时40分，Athira Pharma, Inc.股票出现波动，股价大幅跳水5.00%。Athira Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071621403997a88529&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071621403997a88529&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ATHA"],"gpt_icon":0},{"id":"2551118402","title":"Athira Pharma, Inc.盘中异动 快速下跌5.70%报0.410美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551118402","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551118402?lang=zh_cn&edition=full","pubTime":"2025-07-14 22:01","pubTimestamp":1752501696,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日22时01分，Athira Pharma, Inc.股票出现异动，股价急速下跌5.70%。Athira Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Promis Neurosciences Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为1827.25%、681.23%、495.83%，振幅较大的相关个股有Promis Neurosciences Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.，振幅分别为210.04%、120.70%、115.31%。Athira Pharma, Inc.公司简介：Athira Pharma Inc .是一家后期临床阶段的生物制药公司，专注于开发用于恢复神经元健康和减缓神经变性的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714220137a44a2b39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714220137a44a2b39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATHA","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.athira.com","stockEarnings":[{"period":"1week","weight":0.801},{"period":"1month","weight":0.4643},{"period":"3month","weight":0.801},{"period":"6month","weight":1.3003},{"period":"1year","weight":0.2719},{"period":"ytd","weight":0.188}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Athira Pharma, Inc.于2011年3月31日在华盛顿州注册成立为M3 Biotechnology，Inc.，并于2015年10月27日在特拉华州重新注册为股份公司。该公司是一家处于临床后期阶段的生物制药公司，致力于开发小型药物分子来恢复神经元健康并阻止神经变性。凭借公司的候选产品，它旨在通过其新颖的作用机制提供快速的认知改善，并改变神经系统疾病的病程。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.022543},{"month":2,"riseRate":0.4,"avgChangeRate":-0.063449},{"month":3,"riseRate":0.2,"avgChangeRate":-0.095008},{"month":4,"riseRate":0.4,"avgChangeRate":-0.068964},{"month":5,"riseRate":0.6,"avgChangeRate":0.065626},{"month":6,"riseRate":0.4,"avgChangeRate":-0.221545},{"month":7,"riseRate":0.6,"avgChangeRate":0.106269},{"month":8,"riseRate":0.4,"avgChangeRate":-0.034355},{"month":9,"riseRate":0.2,"avgChangeRate":-0.224006},{"month":10,"riseRate":0.5,"avgChangeRate":0.036994},{"month":11,"riseRate":0.666667,"avgChangeRate":0.141696},{"month":12,"riseRate":0.666667,"avgChangeRate":0.257777}],"exchange":"NASDAQ","name":"Athira Pharma, Inc.","nameEN":"Athira Pharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Athira Pharma, Inc.(ATHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Athira Pharma, Inc.(ATHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Athira Pharma, Inc.,ATHA,Athira Pharma, Inc.股票,Athira Pharma, Inc.股票老虎,Athira Pharma, Inc.股票老虎国际,Athira Pharma, Inc.行情,Athira Pharma, Inc.股票行情,Athira Pharma, Inc.股价,Athira Pharma, Inc.股市,Athira Pharma, Inc.股票价格,Athira Pharma, Inc.股票交易,Athira Pharma, Inc.股票购买,Athira Pharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Athira Pharma, Inc.(ATHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Athira Pharma, Inc.(ATHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}